Analytical Data
-
Gene name
LMLN
- Application
-
Alternative Names
LMLN; Leishmanolysin-like peptidase; EC 3.4.24.-; Invadolysin
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96KR4
-
Expression Region
1-655aa
-
AA Sequence
MVTTLGPKMAAEWGGGVGYSGSGPGRSRWRWSGSVWVRSVLLLLGGLRASATSTPVSLGSSPPCRHHVPSDTEVINKVHLKANHVVKRDVDEHLRIKTVYDKSVEELLPEKKNLVKNKLFPQAISYLEKTFQVRRPAGTILLSRQCATNQYLRKENDPHRYCTGECAAHTKCGPVIVPEEHLQQCRVYRGGKWPHGAVGVPDQEGISDADFVLYVGALATERCSHENIISYAAYCQQEANMDRPIAGYANLCPNMISTQPQEFVGMLSTVKHEVIHALGFSAGLFAFYHDKDGNPLTSRFADGLPPFNYSLGLYQWSDKVVRKVERLWDVRDNKIVRHTVYLLVTPRVVEEARKHFDCPVLEGMELENQGGVGTELNHWEKRLLENEAMTGSHTQNRVLSRITLALMEDTGRQMLSPYCDTLRSNPLQLTCRQDQRAVAVCNLQKFPKPLPQEYQYFDELSGIPAEDLPYYGGSVEIADYCPFSQEFSWHLSGEYQRSSDCRILENQPEIFKNYGAEKYGPHSVCLIQKSAFVMEKCERKLSYPDWGSGCYQVSCSPQGLKVWVQDTSYLCSRAGQVLPVSIQMNGWIHDGNLLCPSCWDFCELCPPETDPPATNLTRALPLDLCSCSSSLVVTLWLLLGNLFPLLAGFLLCIWH
-
Molecular Weight
99 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LMLN, or Lactic Acid Bacteria Mannan-Like Protein, is a recombinant protein that has garnered attention in biomedical research due to its potential applications in various fields, including immunology, nutrition, and biotechnology. The study of LMLN is rooted in the significance of protein engineering and recombinant DNA technology, enabling scientists to manipulate genetic sequences for the production of proteins with specific desired characteristics. Lactic acid bacteria, known for their probiotic properties, provide a natural source of such proteins, which can be harnessed for enhancing immune responses, improving gut health, and developing novel therapeutic strategies. Researchers are investigating the functional properties of LMLN, focusing on its interactions with the immune system and its ability to modulate inflammatory responses. Given the increasing interest in sustainable and health-promoting food ingredients, the exploration of LMLN's biochemical properties and mechanisms of action is paving the way for innovative applications in functional foods and supplements. Furthermore, as the demand for effective delivery systems for vaccines and therapeutics grows, understanding the potential of LMLN as an adjuvant or carrier protein offers promising pathways for improving vaccine efficacy and developing targeted drug delivery methods. Overall, the research surrounding LMLN represents a confluence of microbiology, molecular biology, and biotechnology, aimed at translating scientific insights into practical health benefits and contributing to the advancement of personalized medicine and nutrition.
